RecruitingEarly Phase 1NCT06483373

A Clinical Study of SPH7854 Granules in Healthy Subjects.

A Single and Multiple Dose-escalation, and Food Effects of Phase I Clinical Study to Evaluate the Tolerability/Safety/Pharmacokinetics of SPH7854 Granules in Healthy Subjects.

Sponsor

Shanghai Pharmaceuticals Holding Co., Ltd

Enrollment

111 participants

Start Date

May 28, 2024

Study Type

INTERVENTIONAL

Conditions

Inflammatory Bowel Disease

Summary

To evaluate the safety of SPH7854 in healthy subjects.

Eligibility

Min Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Placebo and a drug called SPH7854 for people with inflammatory bowel disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.